2020
DOI: 10.1111/cod.13726
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous lymphoid hyperplasia caused by cosmetic lip tattoo successfully treated with tacrolimus 0.1% ointment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 7 publications
0
12
0
Order By: Relevance
“…Regarding treatment, tacrolimus has a long‐term anti‐inflammatory effect. 9 In this case, the patient responded well to topical tacrolimus 0.03% ointment (Figure 1 ). The therapies for different tattoo reactions are limited.…”
mentioning
confidence: 66%
“…Regarding treatment, tacrolimus has a long‐term anti‐inflammatory effect. 9 In this case, the patient responded well to topical tacrolimus 0.03% ointment (Figure 1 ). The therapies for different tattoo reactions are limited.…”
mentioning
confidence: 66%
“…The non-microbiological adverse reactions that have been described in the context of semi-permanent make-up included 25 cases (across 19 case reports) of sarcoidosis-related reactions (Bashinskaya et al 2022, Bombonato et al 2015, Ebrahimiadib et al 2021, Gilhooley et al 2020, Hirai et al 2022, Huisman et al 2019, Ibraheim et al 2023, Iwayama et al 2017, Mirzaei et al 2017, Naeini et al 2017, Nie et al 2022, Tukenmez Demirci et al 2016, Valbuena et al 2017, Vera et al 2018, Tittelbach et al 2018); 17 cases of granulomatous reactions, including papules (Bashinskaya et al 2022, Ebrahimiadib et al 2021, Hinojosa et al 2017, Hirai et al 2022, Huisman et al 2019, Ibraheim et al 2023, Iwayama et al 2017, Leight-Dunn et al 2022, Maier et al 2015, Naeini et al 2017, Nie et al 2022, Suleman et al 2023, Sun & Lao 2023, Tittelbach et al 2018, Tukenmez Demirci et al 2016, Valbuena et al 2017); three cases of allergic reactions (Lahouel et al 2022, Ibraheim et al 2023, Motoki et al 2020), 19 cases of skin-related adverse reactions (Abtahi-Naeini et al 2019, Akoh et al 2021, Bashinskaya et al 2022, Ebrahimiadib et al 2021, Gilhooley et al 2020, Hinojosa et al 2017, Goldberg et al 2018, Hirai et al 2022, Maier et al 2015, Mirzaei et al 2017, Naeini et al 2017, Marcelino et al 2021, Navarro-Triviño et al 2021, Nie et al 2022, Sano et al 2021, Suleman et al 2023, Tierney & Kavanagh 2021, Tittelbach et al 2018, Vera et al 2018) and five cases of eye-related adverse reactions and other adverse reactions (Sano et al 2021, Goldberg et al 2018, Hinojosa et al 2017, Soltany et al 2023, Navarro-Triviño et al 2021).…”
Section: Resultsmentioning
confidence: 99%
“…Both patients had PMU complications, one was a pseudolymphoma. 132,182 Pseudolymphomas in tattooing are usually restricted to a certain colour area and develop with a long delay of months or even years after tattooing. Histologically, these reactions predominantly involve T-lymphocytes, whereas B-lymphocytes are usually found in minor fractions only.…”
Section: Case Reports Of Patch Tested Tattoo Patientsmentioning
confidence: 99%
“…Late readings might be useful, as two positive reactions to tattoo inks were recorded on D8 and D10. Both patients had PMU complications, one was a pseudolymphoma 132,182 . Pseudolymphomas in tattooing are usually restricted to a certain colour area and develop with a long delay of months or even years after tattooing.…”
Section: Patch Test Performance In Tattoo Patientsmentioning
confidence: 99%
See 1 more Smart Citation